malaria
fever
pervas
quit
tropic
develop
region
caus
high
morbid
mortal
causal
organ
protozoan
parasit
genu
plasmodium
spread
human
host
bite
hitherto
infect
femal
anophel
mosquito
cours
bite
salivari
protein
anophel
help
blood
feed
behavior
abil
elicit
host
immun
respons
studi
repres
seri
immunoinformat
approach
design
multiepitop
subunit
vaccin
use
anophel
mosquito
salivari
protein
design
subunit
vaccin
evalu
immunogen
allergen
physiochem
paramet
enhanc
stabil
vaccin
protein
disulfid
engin
perform
region
high
mobil
codon
adapt
silico
clone
also
perform
ensur
higher
express
design
subunit
vaccin
e
coli
express
system
final
molecular
dock
simul
studi
perform
vaccin
protein
receptor
determin
bind
free
energi
complex
stabil
moreov
design
subunit
vaccin
found
induc
antisalivari
immun
may
abil
prevent
entri
plasmodium
sporozoit
human
host
malaria
still
remain
one
devast
deadli
infecti
diseas
character
intermitt
high
fever
anoth
form
name
cerebr
malaria
lead
neurolog
complic
brain
injuri
coma
per
world
health
organ
latest
estim
almost
million
case
malaria
along
death
report
decemb
among
countri
worldwid
high
risk
develop
malari
infect
among
popul
group
depend
upon
sever
factor
includ
presenc
children
age
year
patient
hiv
coinfect
pregnant
woman
mobil
popul
travel
causal
organ
malaria
protozoan
parasit
belong
genu
plasmodium
spread
bite
hitherto
infect
femal
anophel
mosquito
mainli
four
speci
plasmodium
name
p
falciparum
p
oval
p
malaria
p
vivax
respons
disastr
diseas
condit
among
human
recent
p
knowlesi
consid
fifth
speci
abil
caus
human
malaria
infect
southeast
asian
countri
mainli
malaysia
talk
sever
infect
distribut
diseas
p
falciparum
sever
form
parasit
lead
death
wherea
p
vivax
wide
distribut
human
parasit
outsid
subsaharan
region
africa
caus
huge
morbid
life
cycl
malaria
parasit
consist
four
stage
name
liver
stage
blood
stage
transmiss
stage
human
last
one
mosquito
stage
keep
mind
end
goal
destroy
ailment
stage
ought
consid
treatment
artemisinin
combin
therapi
firstlin
treatment
p
falciparum
infect
region
chloroquin
resist
evolv
along
fast
onset
action
artemisinin
deriv
rapid
clearanc
human
bodi
need
combin
slowclear
drug
increas
drug
efficaci
kill
remain
parasit
wide
use
combin
therapi
artemetherlumefantrin
commerci
name
coartem
amodiaquineartesun
commerci
name
coarsucam
recent
approv
combin
therapi
artesunatepyronaridin
commerci
name
pyramax
dihydroartemisininpiperaquin
euartesim
recent
emerg
resist
artemisinin
urg
develop
new
strategi
prevent
malaria
diseas
condit
therefor
studi
appli
novel
immunoinformat
approach
design
multiepitop
base
subunit
vaccin
may
prevent
diseas
maintain
host
hemostasi
inhibit
anticoagul
antiinflammatori
protein
present
mosquito
saliva
also
inhibit
entri
parasit
within
host
bodi
similar
mechan
apart
way
parasit
enter
host
bodi
vaccin
candid
stop
salivari
proteinmedi
induct
parasit
growth
among
differ
anophelin
vector
anophel
stephensi
subtrop
speci
abundantli
present
indian
subcontin
also
distribut
across
middl
east
south
asia
region
stephensi
transmit
malari
infect
inject
variou
plasmodium
speci
human
host
typic
via
bite
salivari
gland
mosquito
implement
variou
function
surviv
vector
complement
feed
behavior
produc
larg
array
biochem
activ
molecul
immunomodulatori
anticoagul
antiinflammatori
properti
disabl
host
hemostat
respons
success
blood
feed
salivari
protein
antigen
immunogen
natur
help
infect
parasit
protein
salivari
apyras
two
differ
salivari
protein
help
bind
inhibit
platelet
aggreg
respect
salivari
peroxidas
help
heme
bind
peroxidas
activ
put
til
domain
polypeptid
function
trypsin
inhibitor
recent
report
hamadarin
kda
protein
present
anophel
stephensi
saliva
inhibit
activ
plasma
contact
system
ultim
blood
coagul
anoth
protein
anophel
gambi
saliva
name
play
essenti
blood
feed
recent
vijay
et
al
report
salivari
protein
might
util
develop
novel
antimalari
control
strategi
via
innat
immun
protect
malaria
protein
could
likewis
evok
host
igg
respons
natur
condit
mosquito
salivari
gland
surfac
sg
protein
preval
immunogen
compon
present
saliva
abil
induc
immunogen
respons
reason
chose
stephensi
salivari
protein
nation
center
biotechnolog
inform
ncbi
subject
design
multiepitop
subunit
vaccin
allergen
antigen
physiochem
properti
also
obtain
vaccin
protein
moreov
tertiari
structur
predict
follow
refin
perform
get
refin
model
higher
number
residu
favor
region
ramachandran
plot
molecular
dock
molecular
dynam
simul
vaccin
construct
also
perform
check
bind
energi
complex
stabil
final
disulfid
engin
silico
clone
perform
increas
stabil
vaccin
construct
ensur
effect
express
microbi
system
respect
studi
final
repres
novel
approach
develop
malaria
vaccin
use
salivari
protein
instead
parasit
protein
could
help
prevent
plasmodium
infect
human
host
sequenc
retriev
salivari
protein
assur
antigen
conduct
order
design
immunogen
multiepitop
subunit
vaccin
sum
stephensi
salivari
protein
sequenc
retriev
ncbi
protein
databas
major
protein
name
salivari
lysozym
salivari
protein
precursor
salivari
galectin
salivari
lipas
antithrombin
anophelin
salivari
protein
salivari
apyras
salivari
secret
serin
proteas
inhibitor
salivari
defensin
salivari
cecropin
among
salivari
protein
sequenc
protein
found
antigen
predict
antigenpro
sequenc
select
base
score
obtain
probabl
antigen
protein
score
obtain
score
antigen
probabl
clearli
denot
antigen
natur
select
protein
sequenc
use
subunit
vaccin
design
subset
tcell
respons
kill
target
cell
intracellular
viral
bacteri
protozoan
infect
infect
whenev
encount
mhci
mount
antigen
specif
receptor
enter
cell
cycl
perform
sever
mitot
divis
follow
differenti
effector
cell
tri
predict
ctl
receptor
specif
immunogen
epitop
use
netctl
server
total
ctl
epitop
length
obtain
input
salivari
protein
sequenc
next
step
immunogen
epitop
determin
per
instruct
iedb
higher
score
indic
greater
probabl
elicit
immun
respons
therefor
total
ctl
epitop
high
immunogen
score
select
subject
vaccin
design
tabl
helper
tlymphocyt
key
player
humor
cellmedi
immun
respons
therefor
htl
receptor
specif
epitop
probabl
go
crucial
part
prophylact
immunotherapeut
vaccin
salivari
protein
sequenc
subject
iedb
mhcii
epitop
predict
modul
epitop
length
obtain
order
becom
highest
immunogen
epitop
must
lower
percentil
rank
ic
valu
epitop
lowest
percentil
rank
rang
select
vaccin
design
tabl
ic
valu
rang
denot
epitop
lowest
percentil
rank
epitop
intermedi
affin
remain
low
affin
htl
epitop
side
epitop
found
induc
capabl
obtain
posit
score
ifnepitop
server
output
supplementari
tabl
epitop
use
vaccin
construct
construct
multiepitop
subunit
vaccin
final
vaccin
construct
amino
acid
residu
design
use
ctl
htl
epitop
describ
elsewher
supplementari
figur
order
attain
maximum
immun
respons
agonist
use
adjuv
ntermin
site
vaccin
construct
joint
occupi
suitabl
linker
describ
nezafat
et
al
exampl
adjuv
ctl
epitop
combin
togeth
eaaak
linker
intractl
intrahtl
epitop
joint
aay
gpgpg
linker
respect
final
vaccin
construct
obtain
adjuv
linker
ctl
htl
epitop
sequenc
move
ntermin
ctermin
design
subunit
vaccin
consist
immunogen
ctl
ttl
epitop
along
suitabl
adjuv
linker
may
abil
inhibit
entri
malaria
parasit
within
human
host
bodi
bcell
epitop
map
bcell
key
player
humor
immun
epitop
correspond
bcell
receptor
play
import
role
vaccin
design
follow
antibodi
product
therefor
bcpred
server
use
reliabl
predict
linear
bcell
epitop
bcpred
select
predict
method
total
bcell
epitop
length
predict
among
primari
input
sequenc
final
vaccin
construct
among
epitop
select
final
high
score
fig
due
select
highest
score
bcell
epitop
among
design
subunit
vaccin
vaccin
may
abil
enhanc
humor
immun
well
cell
mediat
immun
discontinu
epitop
amino
acid
long
also
predict
final
model
vaccin
construct
probabl
score
fig
obtain
probabl
score
also
confirm
immunogen
behavior
design
subunit
vaccin
antigen
allergen
predict
design
vaccin
vaccin
given
human
host
must
immunogen
natur
capabl
trigger
signific
humor
immun
respons
ultim
lead
memori
cell
format
pathogen
epitop
antigen
design
vaccin
construct
determin
use
alignmentfre
antigenpro
server
found
antigen
probabl
repres
antigen
natur
vaccin
construct
antigen
score
obtain
vaccin
construct
compar
antigen
subunit
vaccin
report
elsewher
allergi
overreact
immun
system
previous
encount
ordinarili
harmless
substanc
result
sneez
wheez
skin
rash
swell
mucou
membran
allergen
predict
vaccin
construct
determin
use
allertop
onlin
server
found
vaccin
protein
nonallerg
natur
safe
human
use
physiochem
properti
assess
physiochem
properti
vaccin
construct
character
use
protparam
server
evalu
seven
paramet
molecular
weight
vaccin
protein
found
kda
favor
antigen
vaccin
construct
theoret
pi
found
show
slightli
acid
natur
total
number
neg
posit
charg
residu
respect
estim
halflif
mammalian
reticulocyt
hour
vitro
hour
yeast
e
coli
vivo
extinct
coeffici
found
nm
measur
water
assum
cystein
residu
reduc
score
obtain
instabl
index
show
stabl
natur
vaccin
construct
valu
aliphat
index
grand
averag
hydropath
gravi
respect
estim
valu
aliphat
index
repres
thermost
natur
design
subunit
vaccin
higher
valu
aliphat
index
greater
thermo
stabil
neg
valu
gravi
input
subunit
vaccin
repres
hydrophil
natur
vaccin
conclus
design
vaccin
immunogen
thermost
hydrophil
natur
tertiari
structur
predict
refin
valid
tertiari
structur
predict
use
raptorx
server
model
obtain
describ
elsewher
fig
best
templat
use
homolog
model
crystal
structur
legionella
phosphoinositid
phosphatas
pdb
id
total
amino
acid
residu
model
singl
domain
disord
secondari
structur
inform
result
presenc
helix
beta
sheet
coil
structur
pvalu
paramet
homolog
model
low
pvalu
defin
good
qualiti
model
structur
pvalu
obtain
model
structur
low
signific
protein
refin
use
galaxyrefin
lead
increas
number
residu
favor
region
initi
residu
ramafavor
region
refin
number
residu
ramafavor
region
reach
refin
output
also
valid
plot
ramachandran
plot
found
residu
ramafavor
region
residu
allow
region
residu
outlier
region
fig
disulfid
engin
vaccin
stabil
order
stabil
model
structur
final
vaccin
construct
disulfid
engin
perform
use
disulfid
design
found
total
pair
residu
use
purpos
disulfid
engin
evalu
paramet
like
energi
valu
four
pair
residu
final
valu
come
allow
rang
ie
valu
energi
less
degre
therefor
total
mutat
creat
residu
pair
name
fig
codon
adapt
silico
clone
main
purpos
silico
clone
express
vaccin
protein
epitop
anophel
mosquito
origin
e
coli
express
system
therefor
necessari
adapt
codon
respect
subunit
vaccin
construct
per
codon
usag
e
coli
express
system
adapt
codon
per
e
coli
strain
use
jcat
server
found
gccontent
improv
sequenc
valu
codon
adapt
index
near
satisfactori
later
xhoi
ndei
restrict
site
creat
clone
vector
fig
target
sequenc
clone
repres
blue
color
aforement
restrict
site
target
sequenc
also
enclos
residu
end
help
purif
purpos
total
length
clone
receptor
perform
use
cluspro
total
model
gener
among
model
select
properli
occupi
receptor
lowest
energi
score
found
model
number
fulfil
desir
criteria
select
bestdock
complex
fig
energi
score
obtain
model
found
lowest
among
predict
dock
complex
show
highest
bind
affin
form
use
gromac
use
forc
field
potenti
energi
obtain
complex
kjmol
valu
temperatur
pressur
densiti
obtain
k
bar
kgm
supplementari
figur
radiu
gyrat
obtain
dock
complex
show
distanc
rotat
complex
center
mass
nanomet
decreas
time
durat
nanosecond
supplementari
figur
rmsd
valu
protein
backbon
nanomet
fig
rmsf
score
obtain
protein
side
chain
found
nanomet
fig
score
satisfactori
show
strong
complex
stabil
malaria
sever
infect
character
high
fever
irregular
may
also
lead
brain
injuri
coma
affect
million
peopl
countri
worldwid
lack
effect
vaccin
emerg
resist
artemisinin
creat
disastr
condit
among
peopl
live
endem
zone
therefor
need
time
search
new
option
tackl
sever
problem
vector
malaria
anophel
stephensi
indian
subcontin
lead
transfer
malaria
parasit
literatur
survey
reveal
salivari
protein
anophel
mosquito
support
pathogenesi
also
immunogen
natur
therefor
studi
design
reach
step
ahead
path
vaccin
develop
use
primari
amino
acid
sequenc
anophel
mosquito
salivari
protein
design
subunit
vaccin
construct
construct
vaccin
ctl
htl
bcl
epitop
vari
length
antigen
properti
absenc
allergen
properti
stabl
good
bind
affin
receptor
collect
studi
appli
seri
immunoinformat
tool
sequenti
manner
find
effect
vaccin
may
fight
malaria
infect
howev
studi
need
experiment
valid
prove
comput
work
experiment
work
may
includ
synthesi
design
subunit
vaccin
follow
vitro
vivo
analysi
determin
immunogen
safeti
concern
anophel
stephensi
mosquito
vector
malaria
transmiss
human
indian
subcontin
salivari
gland
protein
anophel
mosquito
report
role
parasit
pathogenesi
abil
induc
igg
respons
natur
host
therefor
total
salivari
protein
stephensi
obtain
nation
center
biotechnolog
inform
ncbi
protein
databas
retriev
date
subject
multiepitop
vaccin
design
main
purpos
vaccin
induc
immunogen
respons
within
host
bodi
retriev
protein
sequenc
subject
antigen
predict
use
antigenpro
base
antigen
result
protein
found
antigen
probabl
select
use
next
step
cytotox
tlymphocyt
shown
inhibit
malaria
parasit
growth
develop
insid
hepatocyt
cell
get
immunogen
ctl
epitop
abil
elicit
cellmedi
immun
form
memori
cell
salivari
protein
sequenc
subject
netctl
server
netctl
onlin
web
server
intend
predict
ctl
epitop
among
input
protein
sequenc
base
train
dataset
netctl
select
predict
ctl
epitop
higher
prescient
execut
execut
paramet
compar
recent
develop
server
name
mhcpathway
mappp
epijen
salivari
protein
sequenc
submit
fasta
format
predict
ctl
epitop
threshold
score
default
epitop
combin
score
greater
select
ctl
epitop
subject
immun
epitop
databas
iedb
mhc
class
immunogen
predict
modul
predict
ctl
epitop
salivari
protein
use
input
sequenc
result
obtain
form
score
higher
score
determin
greater
probabl
elicit
immun
respons
helper
tlymphocyt
htl
epitop
predict
helper
tcell
respons
major
part
cellmedi
immun
help
pathogen
clearanc
help
variou
cytokin
immun
cell
abil
induc
ctl
humor
immun
respons
secret
lymphokin
like
granulocytemacrophag
colonystimul
factor
gmcsf
view
say
htl
epitop
mainli
type
like
go
crucial
part
prophylact
immunotherapeut
vaccin
therefor
iedb
mhcii
epitop
predict
modul
use
predict
htl
epitop
anophel
salivari
protein
sequenc
avail
paramet
kept
default
except
allel
select
nomin
allel
output
epitop
rank
base
percentil
rank
score
lower
percentil
rank
repres
greater
bind
affin
htl
receptor
secondli
prove
work
predict
htl
epitop
abil
activ
type
immun
respons
follow
product
top
predict
htl
epitop
subject
ifn
epitop
server
use
predict
option
epitop
submit
fasta
format
follow
approach
select
model
predict
motif
svm
hybrid
select
approach
ifngamma
versu
cytokin
model
predict
design
multiepitop
subunit
vaccin
plan
appropri
vaccin
candid
must
abil
induc
ctl
htl
immun
respons
word
subunit
vaccin
must
contain
ctl
htl
epitop
along
suitabl
linker
keep
mind
end
goal
effect
activ
innat
adapt
immun
respons
subunit
vaccin
must
consist
strong
immunostimulatori
adjuv
previou
decad
huge
headway
adjuv
engin
instanc
tolllik
receptor
tlr
agonist
made
contribut
part
peptidebas
subunit
vaccin
function
option
presentday
immunotherapi
recent
junqueira
et
al
shown
cpg
oligodeoxynucleotid
cpg
odn
glycoinositolphospholipid
gipl
gotten
trypanosom
cruzi
abil
activ
lead
actuat
potent
proinflammatori
reaction
secondli
proteoglycolipid
complex
deriv
leishmania
parasit
shown
affin
receptor
recogn
ligand
moreov
tlr
capabl
recogn
plasmodium
ligand
exampl
plasmodium
falciparum
prime
human
respons
toward
high
proinflammatori
cytokin
profil
shanmugam
et
report
synthet
agonist
name
sequenc
apphal
use
novel
class
adjuv
therefor
ad
adjuv
link
epitop
ctl
htl
use
eaaak
linker
linker
assum
imper
part
simul
vaccin
construct
work
independ
immunogen
produc
higher
antibodi
titer
singl
immunogen
total
three
linker
name
eaaak
aay
gpgpg
use
construct
final
vaccin
aay
gpgpg
linker
ad
intraepitop
posit
link
ctl
htl
epitop
respect
bcell
epitop
predict
b
lymphocyt
type
white
blood
cell
key
player
humor
immun
antibodi
product
identif
bcell
epitop
essenti
part
vaccin
design
bcpred
server
use
predict
linear
bcell
epitop
amino
acid
long
amino
acid
sequenc
final
vaccin
construct
use
input
sequenc
plain
format
follow
select
fix
length
epitop
predict
method
length
epitop
bcpred
default
method
select
predict
method
epitop
amino
acid
long
specif
threshold
set
default
get
result
userfriendli
format
conform
epitop
predict
use
ellipro
server
input
tertiari
protein
structur
vaccin
construct
antigen
allergen
predict
design
vaccin
antigen
determin
abil
antigen
bind
band
tcell
receptor
may
lead
immun
respons
memori
cell
format
therefor
antigen
natur
predict
vaccin
construct
determin
ensur
abil
interact
immun
receptor
antigenpro
sequenc
base
pathogen
independ
alignmentfre
predict
method
use
check
antigen
behavior
vaccin
protein
use
svm
classifi
summar
probabl
antigen
nonantigen
natur
protein
antigenpro
use
exist
protein
antigen
microarray
file
eight
featur
set
five
pathogen
construct
twostag
architectur
among
first
one
multipl
represent
primari
protein
sequenc
second
one
five
machin
learn
algorithm
allergen
potenti
materi
caus
sensit
allerg
reaction
associ
ige
antibodi
respons
therefor
predict
vaccin
construct
must
free
allergen
natur
allertop
v
use
check
allergen
vaccin
construct
base
method
use
auto
crosscovari
acc
transform
protein
sequenc
uniform
equallength
vector
input
protein
sequenc
vaccin
protein
classifi
knearest
neighbor
algorithm
knn
k
base
train
set
known
allergen
differ
speci
nonallergen
similar
speci
physiochem
properti
assess
main
purpos
vaccin
induc
immun
respons
inject
vaccin
bodi
therefor
necessari
defin
physic
chemic
paramet
associ
vaccin
protparam
web
server
part
expert
protein
analysi
system
expasi
use
defin
variou
physicochem
properti
predict
vaccin
construct
primari
protein
sequenc
vaccin
use
predict
variou
paramet
includ
molecular
weight
kda
estim
halflif
theoret
pi
aliphat
index
grand
averag
hydropathi
gravi
tertiari
structur
predict
protein
molecul
achiev
maximum
stabil
lowest
energi
state
proper
bend
twist
form
tertiari
structur
interact
amino
acid
side
chain
residu
respons
stabil
protein
structur
structur
predict
vaccin
construct
obtain
util
raptorx
structur
predict
server
raptorx
pure
ab
initio
method
use
build
model
templatefre
manner
degre
like
target
avail
templat
structur
determin
qualiti
protein
model
structur
creat
contemporari
protein
structur
predict
techniqu
therefor
necessari
improv
templat
base
predict
model
beyond
accuraci
util
templat
inform
fulfil
thought
output
model
raptorx
server
subject
galaxyrefin
web
server
base
test
refin
method
galaxyrefin
perform
rehash
structur
perturb
follow
overal
structur
relax
perform
molecular
dynam
simul
disulfid
engin
vaccin
stabil
proceed
next
step
necessari
improv
stabil
refin
protein
model
disulfid
bond
coval
interact
emul
stabil
molecular
interact
provid
consider
stabil
protein
model
confirm
precis
geometr
conform
disulfid
engin
novel
approach
creat
disulfid
bond
target
protein
structur
therefor
refin
model
final
vaccin
construct
subject
disulfid
design
perform
disulfid
engin
initi
refin
protein
model
upload
run
residu
pair
search
use
disulfid
engin
purpos
total
residu
pair
select
mutat
cystein
residu
use
creat
mutat
function
disulfid
design
server
silico
clone
codon
adapt
way
attain
major
express
rate
foreign
gene
host
codon
usag
host
differ
organ
gene
stem
unadapt
codon
may
lead
minor
express
rate
host
therefor
primari
sequenc
vaccin
protein
submit
java
codon
adapt
tool
jcat
adapt
codon
usag
sequenc
prokaryot
organ
e
coli
cai
valu
gc
content
adapt
sequenc
also
obtain
later
adapt
nucleotid
sequenc
correspond
design
vaccin
construct
clone
e
coli
vector
use
restrict
clone
modul
snapgen
tool
use
predict
prefer
orient
ligand
molecul
receptor
molecul
stabl
complex
form
also
use
predict
bind
affin
two
molecul
term
score
function
mention
previou
section
tlr
capabl
recogn
plasmodium
ligand
p
falciparum
prime
human
respons
toward
high
proinflammatori
cytokin
profil
therefor
select
receptor
pdb
file
pdb
id
obtain
rcsbprotein
data
bank
refin
model
vaccin
protein
use
ligand
proteinprotein
dock
perform
use
cluspro
proteinprotein
dock
server
check
bind
affin
wide
accept
comput
approach
use
determin
stabil
proteinligand
complex
microscop
level
proteinprotein
dock
complex
output
cluspro
use
input
perform
molecular
dynam
simul
use
gromac
initi
crystal
water
complex
remov
follow
topolog
gener
use
forc
field
next
step
protein
complex
center
cubic
boundari
box
fill
water
molecul
use
simpl
point
charg
spc
water
model
chlorid
ion
use
charg
neutral
complex
moreov
energi
minim
follow
canon
equilibr
nvt
ensembl
isothermalisobar
npt
ensembl
perform
time
durat
ps
final
molecular
dynam
simul
execut
time
durat
root
mean
squar
deviat
rmd
backbon
root
mean
squar
fluctuat
rmsf
side
chain
determin
